Key terms

About XNCR

Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest XNCR news

Apr 09 8:32am ET Xencor Inc Announces CFO Transition and Executive Compensation Plan by TipRanks Mar 01 1:01am ET Bad News for Xencor Inc. Stock: This New Risk Has Been Added by TipRanks Mar 01 1:01am ET Xencor’s Strategic Focus and Pipeline Progress Affirm Buy Rating by TipRanks Feb 28 12:40pm ET Xencor downgraded to Neutral at Piper after death of patient using vudalimab by TipRanks Feb 28 12:33pm ET Xencor downgraded to Neutral from Overweight at Piper Sandler by TipRanks Feb 28 8:54am ET Xencor price target lowered to $34 from $38 at BMO Capital by TipRanks Feb 28 8:47am ET Xencor price target lowered to $34 from $36 at Wedbush by TipRanks Feb 28 7:19am ET Xencor price target raised to $38 from $36 at Canaccord by TipRanks Feb 28 7:16am ET Xencor (XNCR) Receives a Buy from RBC Capital by TipRanks Feb 28 7:02am ET Analysts Are Bullish on Top Healthcare Stocks: Alcon (ALC), Xencor (XNCR) by TipRanks Feb 28 6:20am ET Analysts Offer Insights on Healthcare Companies: Xencor (XNCR) and Vaxcyte (PCVX) by TipRanks Feb 28 3:36am ET Barclays Sticks to Their Sell Rating for Xencor (XNCR) by TipRanks Feb 27 9:35pm ET Xencor (XNCR) Gets a Buy from TD Cowen by TipRanks Feb 27 4:08pm ET Xencor expects cash to fund operations into 2027 by TipRanks Feb 27 4:06pm ET Xencor reports Q4 EPS (31c), consensus (9c) by TipRanks

No recent news articles are available for XNCR

No recent press releases are available for XNCR

XNCR Financials

1-year income & revenue

Key terms

XNCR Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

XNCR Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel
JPMorgan beat earnings expectations this Friday, unofficially kicking off the first quarter earnings season.
Win McNamee/Getty Images
Jamie Dimon says chance of a bad economy is ‘higher than other people think’